Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators.
about
Serum uric acid and adiposity: deciphering causality using a bidirectional Mendelian randomization approachFirst nationwide survey on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-LUX)Does abdominal obesity accelerate the effect of hypertriglyceridemia on impaired fasting glucose?The relation between body fat distribution and cardiovascular risk factors in patients with schizophrenia: a cross-sectional pilot studyHeritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study.Systemic inflammation and the metabolic syndrome among middle-aged community volunteers.High plasma uric acid concentration: causes and consequences.Chronic activation of the innate immune system may underlie the metabolic syndrome.A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population.Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering.Factor structure underlying components of allostatic loadA comparison of predictability of cardiovascular events between each metabolic component in patients with metabolic syndrome based on the revised National Cholesterol Education Program criteria.The management of hyperuricemia and gout in patients with heart failure.The Association between Serum Uric Acid Level and Incidence of Metabolic Syndrome according to Menopausal Status in Korean Women.Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms.A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT).Does obesity or hyperuricemia influence lithogenic risk profile in children with urolithiasis?Hyperuricemia as a Potential Determinant of Metabolic Syndrome.Hyperlipidaemia in hyperuricaemia and gout.White Rice Intake Varies in Its Association with Metabolic Markers of Diabetes and Dyslipidemia Across Region among Chinese Adults.Relationship between hyperuricemia and metabolic syndromeEffects of dietary protein intake on body composition changes after weight loss in older adults: a systematic review and meta-analysisAssociation between serum uric acid level and metabolic syndrome components.Are cardiometabolic and endocrine abnormalities linked to sleep difficulties in schizophrenia? A hypothesis driven reviewDietary, anthropometric, and biochemical determinants of uric acid in free-living adultsUric acid and the development of metabolic syndrome in women and menEvaluation of two single-factor models of metabolic syndrome: a confirmatory factor analysis for an adult population in BeijingGenetic and environmental contributions to phenotypic components of metabolic syndrome: a population-based twin studyPrevalence of metabolic syndrome in turkmen ethnic groups in gorgan.Heritability of phenotypes associated with glucose homeostasis and adiposity in a rural area of Brazil.Glycated hemoglobin and cancer incidence and mortality in the Atherosclerosis in Communities (ARIC) Study, 1990-2006.Evaluation of Association of Hyperuricaemia with Metabolic Syndrome and Insulin Resistance.Renal histopathological findings in relation to ambulatory blood pressure in chronic kidney disease patients.Comparative evaluation of anthropometric measures to predict cardiovascular risk factors in Tehranian adult women.Effect of fenofibrate in combination with urate lowering agents in patients with gout.Febuxostat (Feburic tablet) in the management of hyperuricemia in a general practice cohort of Japanese patients with a high prevalence of cardiovascular problems.Serum uric acid, inflammation, and nondipping circadian pattern in essential hypertension.Obesity, fasting plasma insulin, and C-reactive protein levels in healthy children.Fasting plasma insulin modulates lipid levels and particle sizes in 2- to 3-year-old children.The metabolic syndrome and coronary heart disease in older women: findings from the British Women's Heart and Health Study.
P2860
Q28728265-DE5201A1-D8B5-483C-9E89-DD9C3ED62121Q33653585-D7D68C65-B1E1-463E-AA47-A8225CA73BBCQ33781938-06BF5585-1555-4538-B106-0E7F389F93C2Q33873589-D3C018F9-B333-4C0C-94C9-236AACC929B3Q34147834-9CF9E217-8C0C-4B63-ADC6-EEC91AC4B401Q34200504-BD1034D7-AB32-4211-9ACB-7684C7012813Q34265901-3ABABF08-3999-40F2-B276-C27659E93A22Q34273089-1648E3DE-0C5D-4CD4-8669-3C1C76FA4821Q34298031-A570967A-6A04-4CE3-A4B3-FFC932450071Q34404827-51CEE3A7-A632-4798-929F-98E3EF3103C3Q34462148-A5838C88-3640-408D-9283-E5F7D5698D5CQ34635460-CF55CB28-9A69-4FE1-92EC-1557BAF280D9Q34776806-EDF9A868-C985-461D-9067-5714A4D81CF2Q34863749-D0DA38BC-4B84-45B4-A728-0D8278592E9FQ35009785-75DCFE4C-9DA9-4FA7-9E7A-53677F9D3B28Q35038338-2DE2DCE4-1B88-4204-8E50-F5C2AA9E4A7EQ35214625-E2CD4806-C7A6-463A-B76F-C00B82993B91Q35332690-4575BFC6-D04D-4396-811B-67F1EFDD509BQ35548133-D7993699-5C6E-4278-941A-356ADA296989Q35908591-0352B047-29F3-47F7-AF6F-38C8B687F355Q35916892-CA6281F4-8570-4D6C-A4E5-501F878140D1Q35925489-C4CDDBCF-2A06-4E2C-ADDE-CCF24339D97EQ36061539-BDF9208C-A2C5-46D1-9A49-94BAF70BE18AQ36600817-B25B09FD-E219-45BF-9C30-FBE5DD16543AQ36614090-2D286949-0A71-4ABF-B9A6-17D899DBEDFAQ36794999-C5C15FFB-6C7E-4125-9A44-7AE09F93FBE5Q36859151-35AE0FCE-AB78-46A7-9930-8DA1746C032BQ37154939-46CD3F87-4333-46D6-A9D0-496B2B11E35CQ37258789-A9CFA37B-CF10-405B-9C01-851A62440C7CQ37416879-5F840127-3167-4CD2-9B8C-14CE124763F2Q37529862-06F3EC08-BA05-4F79-8092-1275FAF66B66Q37630080-1C06C011-9B57-4860-A59F-E581D3FB7059Q39127448-A754C92E-D085-44DF-AAE3-8F9A7E11C069Q39745788-CF1BE58F-E414-4220-BDAC-3792AEBB221DQ41869801-C580D0AF-4242-4A0C-91F6-3CB78211FD5FQ43545502-5797B5AD-E63D-41E6-B993-329C7917907CQ44218513-73D4A131-3147-49C5-960A-8B6523482CECQ44279278-BBD62F21-9071-468E-88D3-B20686179E15Q44477343-60322972-7465-4497-BBFF-1FD5B7F91E75Q44550800-9FE62AA5-BC53-4424-842B-B25F80C8170B
P2860
Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Clustering of dyslipidemia, hy ...... mmunities Study Investigators.
@en
Clustering of dyslipidemia, hy ...... mmunities Study Investigators.
@nl
type
label
Clustering of dyslipidemia, hy ...... mmunities Study Investigators.
@en
Clustering of dyslipidemia, hy ...... mmunities Study Investigators.
@nl
prefLabel
Clustering of dyslipidemia, hy ...... mmunities Study Investigators.
@en
Clustering of dyslipidemia, hy ...... mmunities Study Investigators.
@nl
P2093
P921
P1433
P1476
Clustering of dyslipidemia, hy ...... mmunities Study Investigators.
@en
P2093
A R Sharrett
B B Duncan
F L Brancati
M I Schmidt
R L Watson
P304
P356
10.1016/S0026-0495(96)90134-1
P577
1996-06-01T00:00:00Z